- A Phase III, Open-label, Randomised Study of Neoadjuvant Datopotamab Deruxtecan (Dato-DXd) Plus Durvalumab Followed by Adjuvant Durvalumab With or Without Chemotherapy Versus Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembroliz awarded by AstraZeneca Pharmaceuticals, LP 2024 - 2029
- Lee, Michael S., Samantha M. Thomas, Anna D. Louie, Laura H. Rosenberger, Rani Bansal, Gayle DiLalla, Kendra J. M. Parrish, et al. “Comparison of survival outcomes for patients with Stage III vs de novo Stage IV breast cancer.” Cancer 131, no. 10 (May 15, 2025): e35891. https://doi.org/10.1002/cncr.35891.
- Bansal, Rani, Tolulope Adeyelu, Andrew Elliott, Phillip Walker, Matias A. Bustos, Estelamari Rodriguez, Melissa K. Accordino, et al. “Genomic and transcriptomic landscape of HER2-low breast cancer.” Breast Cancer Res Treat 209, no. 2 (January 2025): 323–30. https://doi.org/10.1007/s10549-024-07495-4.
- Barnett, Reagan M., Albert Jang, Sree Lanka, PIngfu Fu, Leslie A. Bucheit, Hani Babiker, Alan Bryce, et al. “Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers.” Commun Med (Lond) 4, no. 1 (December 2, 2024): 256. https://doi.org/10.1038/s43856-024-00687-5.
- Bansal, R., D. Dizon, and M. Murphy. “Ovarian Cancer: Primary Treatment and Approach to Recurrent Disease.” In Cancer Consult: Expertise in Clinical Practice, Volume 1: Solid Tumors and Supportive Care, 1:499–509, 2023. https://doi.org/10.1002/9781119823766.ch38.
- Borgovan, T., A. Pelcovitz, R. Chudasama, T. Ollila, and P. Queseneberry. “The Stem Cell Continuum Model and Implications in Cancer.” In Handbook of Stem Cell Therapy: Volume 1, 1255–78, 2022. https://doi.org/10.1007/978-981-19-2655-6_24.
- Dent, Susan, Emily Douglas, Sarah Hatcher, Katherine Ansley, Carolyn Park, Nathaniel O’Connell, Mary Hackney, et al. “Abstract PO3-19-04: The CROWN STUDY: A multicenter prospective cohort study of cardiovascular outcomes in premenopausal women with hormone receptor positive breast cancer treated with ovarian suppression and an aromatase inhibitor.” In Cancer Research, Vol. 84. American Association for Cancer Research (AACR), 2024. https://doi.org/10.1158/1538-7445.sabcs23-po3-19-04.
- Bansal, Rani, Tolulope Adeyelu, Andrew Elliott, Antoinette Tan, Jane Meisel, Matthew Oberley, Stephanie Graff, et al. “Abstract PO4-24-08: Genomic Landscape of Malignant Phyllodes Tumors Identifies Subsets for Targeted Therapy.” In Cancer Research, Vol. 84. American Association for Cancer Research (AACR), 2024. https://doi.org/10.1158/1538-7445.sabcs23-po4-24-08.
- Lee, Seoho, Rani Bansal, Melissa E. Hughes, Amanda E. Van Swearingen, Heather N. Moore, David O. Kamson, Solmaz Sahebjam, et al. “Abstract 6472: Response to PARP inhibitors in patients with breast cancer metastatic to the central nervous system.” In Cancer Research, 84:6472–6472. American Association for Cancer Research (AACR), 2024. https://doi.org/10.1158/1538-7445.am2024-6472.
Patient Reviews
Patient comments are gathered from our Press Ganey Patient Survey and displayed in their entirety.
Patients are de-identified for confidentiality and patient privacy